(primary solid tumor cohort)
This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and subtypes.
Testing the association between copy number variation 38 arm-level results and molecular subtype 'METHLYATION_CNMF' across 20 patients, no significant finding detected with Q value < 0.25.
-
No arm-level cnvs related to molecular subtypes.
Table 1. Get Full Table Overview of the association between significant copy number variation of 38 arm-level results and 1 molecular subtypes. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, no significant finding detected.
Molecular subtypes |
METHLYATION CNMF |
||
nCNV (%) | nWild-Type | Fisher's exact test | |
1q gain | 4 (20%) | 16 |
0.569 (1.00) |
2p gain | 3 (15%) | 17 |
0.711 (1.00) |
3p gain | 4 (20%) | 16 |
1 (1.00) |
3q gain | 7 (35%) | 13 |
0.223 (1.00) |
5p gain | 6 (30%) | 14 |
1 (1.00) |
7p gain | 7 (35%) | 13 |
0.164 (1.00) |
7q gain | 6 (30%) | 14 |
1 (1.00) |
8p gain | 7 (35%) | 13 |
0.553 (1.00) |
8q gain | 11 (55%) | 9 |
0.835 (1.00) |
9q gain | 4 (20%) | 16 |
1 (1.00) |
10p gain | 4 (20%) | 16 |
0.0788 (1.00) |
12p gain | 9 (45%) | 11 |
0.0677 (1.00) |
14q gain | 4 (20%) | 16 |
0.569 (1.00) |
17p gain | 5 (25%) | 15 |
0.198 (1.00) |
17q gain | 5 (25%) | 15 |
0.147 (1.00) |
18p gain | 4 (20%) | 16 |
1 (1.00) |
20p gain | 10 (50%) | 10 |
1 (1.00) |
20q gain | 10 (50%) | 10 |
1 (1.00) |
21q gain | 3 (15%) | 17 |
1 (1.00) |
22q gain | 5 (25%) | 15 |
1 (1.00) |
Xq gain | 4 (20%) | 16 |
1 (1.00) |
3p loss | 7 (35%) | 13 |
0.655 (1.00) |
4p loss | 6 (30%) | 14 |
0.51 (1.00) |
4q loss | 5 (25%) | 15 |
0.198 (1.00) |
5p loss | 4 (20%) | 16 |
0.569 (1.00) |
5q loss | 4 (20%) | 16 |
0.569 (1.00) |
6p loss | 6 (30%) | 14 |
0.51 (1.00) |
6q loss | 3 (15%) | 17 |
1 (1.00) |
9p loss | 3 (15%) | 17 |
0.344 (1.00) |
10p loss | 4 (20%) | 16 |
1 (1.00) |
10q loss | 3 (15%) | 17 |
0.711 (1.00) |
11p loss | 3 (15%) | 17 |
0.711 (1.00) |
13q loss | 7 (35%) | 13 |
0.223 (1.00) |
16q loss | 4 (20%) | 16 |
1 (1.00) |
18p loss | 6 (30%) | 14 |
0.408 (1.00) |
18q loss | 7 (35%) | 13 |
1 (1.00) |
21q loss | 10 (50%) | 10 |
0.443 (1.00) |
22q loss | 3 (15%) | 17 |
0.518 (1.00) |
-
Mutation data file = broad_values_by_arm.mutsig.cluster.txt
-
Molecular subtypes file = ESCA-TP.transferedmergedcluster.txt
-
Number of patients = 20
-
Number of significantly arm-level cnvs = 38
-
Number of molecular subtypes = 1: 'METHLYATION_CNMF'
-
Exclude genes that fewer than K tumors have mutations, K = 3
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.